Ontology highlight
ABSTRACT:
SUBMITTER: Kawai Y
PROVIDER: S-EPMC3100224 | biostudies-literature | 2011
REPOSITORIES: biostudies-literature
Kawai Yasuyuki Y Sato-Ishida Ryoko R Motoyama Atsushi A Kajinami Kouji K
Drug design, development and therapy 20110511
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, known as statins, have revolutionized the treatment of hypercholesterolemia and coronary artery disease prevention. However, there are considerable issues regarding statin safety and further development of residual risk control, particularly for diabetic and metabolic syndrome patients. Pitavastatin is a potent statin with low-density lipoprotein (LDL) cholesterol-lowering effects comparable to those of atorvastatin or rosu ...[more]